Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

Sky Labs' CART-I ring – described as a cardio tracker – achieved 84.6% sensitivity compared to 69.1% for the Apple Watch, ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

This July, the 13 th Tumor Models Summit Boston returns, uniting 180+ preclinical and translational experts from biopharma ...

The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies for rare and common diseases. With momentum building from ...

The study enrolled patients with a PD-L1 combined positive score (CPS) of 10 or more, matching Keytruda's label in first-line ...

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...

March was a light month across the board for hires news, but the digital and supplier sectors in biopharma saw a spat of ...

This new approach to lab space is emblematic of a broader trend in real estate: the conversion of under-utilised office space ...